+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

Growth Opportunities In Gene Editing Technologies, Advanced RNA Therapeutics, Antibody Drug Conjugates and Biomanufacturing - Product Thumbnail Image

Growth Opportunities In Gene Editing Technologies, Advanced RNA Therapeutics, Antibody Drug Conjugates and Biomanufacturing

  • Report
  • October 2022
  • 68 Pages
  • Global
Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions - Product Thumbnail Image

Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions

  • Report
  • October 2019
  • 427 Pages
  • Global
From
Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by Indication (B-cell Malignancies, Prostate Cancer), by End-use, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by Indication (B-cell Malignancies, Prostate Cancer), by End-use, by Region, and Segment Forecasts, 2022-2030

  • Report
  • July 2022
  • 165 Pages
  • Global
From
Cellular Immunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Cellular Immunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 171 Pages
  • Global
From
NK Cell therapies - Pipeline Insight, 2024 - Product Thumbnail Image

NK Cell therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
CAR-T Therapy Global Market Report 2024 - Product Thumbnail Image

CAR-T Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Immuno-Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Tumor Infiltrating Lymphocytes Global Market Report 2024 - Product Thumbnail Image

Tumor Infiltrating Lymphocytes Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • August 2024
  • 500 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Acute Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and Geography - Product Thumbnail Image

Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and Geography

  • Report
  • September 2024
  • 678 Pages
  • Global
From
Allogeneic Cell Therapy Market - Distribution by Type of Cell Therapy, Source of Cell, Target Indication, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Allogeneic Cell Therapy Market - Distribution by Type of Cell Therapy, Source of Cell, Target Indication, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 205 Pages
  • Global
From
Europe Cell & Gene Therapy Market - Focused Insights 2024-2029 - Product Thumbnail Image

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

  • Report
  • June 2024
  • 103 Pages
  • Europe
From
Loading Indicator